Gilead Sciences logo

Gilead Sciences Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Gilead Sciences holds $56.3B in total assets. Shareholders' equity is $23.5B against $22.2B in total debt. Cash and equivalents total $7.6B. The current ratio is 1.97 and debt-to-equity is 0.943. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$166.82B
P/E Ratio18.10
ROE43.19%

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Aggregate Notional Principal Outstanding$2.9B$3.4B$3.7B$3.3B$3.9B$3.6B
Cumulative Cost Basis$7.9B$8.0B$8.1B$8.2B$8.3B$8.4B
Less: allowances for chargebacks$759.0M$717.0M$696.0M$762.0M$843.0M$661.0M
Income taxes payable – long-term$830.0M$819.0M$859.0M$866.0M$896.0M$918.0M
Allowance for doubtful accounts$52.0M$59.0M$50.0M$41.0M$41.0M$44.0M
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax$1.0M$0.0$1.0M$4.0M
Gross Unrealized Gains$6.0M$10.0M$11.0M$1.0M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$7.0M$11.0M$4.0M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$7.0M$11.0M$4.0M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five$1.9B$2.0B$982.0M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five$1.9B$2.0B$979.0M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$79.0M$19.0M$15.0M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$79.0M$19.0M$15.0M
Common stock, par value (in dollars per share)$0.00$0.00$0.00$0.00$0.00$0.00
Common stock, shares authorized (in shares)5.6B5.6B5.6B5.6B5.6B5.6B
Common stock, shares issued (in shares)1.2B1.2B1.2B1.2B1.2B1.2B
Common Stock, Shares, Outstanding1.2B1.2B1.2B1.2B1.2B1.2B
Contract with Customer, Asset, after Allowance for Credit Loss$277.0M$304.0M$305.0M$695.0M$629.0M$589.0M
Contract with Customer, Liability$58.0M$56.0M$58.0M$56.0M$48.0M$47.0M
Short-term debt and current portion of long-term debt$1.8B$2.8B$2.8B$2.8B$2.8B$1.3B
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss$0.0$2.0B$2.0B$3.0B$1.0B
Less than 12 months$519.0M$724.0M$669.0M
Estimated Fair Value$2.0B$2.0B$3.0B$997.0M
Deferred income taxes$724.0M$709.0M$652.0M$597.0M$402.0M$392.0M
Derivative Asset, Subject to Master Netting Arrangement, after Offset and Deduction$125.0M$0.0$2.0M$16.0M$49.0M
Potential reduction in net position of total derivative assets$40.0M$24.0M
Derivative Liability, Subject to Master Netting Arrangement, after Offset and Deduction$0.0$153.0M$63.0M$32.0M$6.0M
Potential reduction in net position of total derivative liabilities$3.0M$25.0M$7.0M$29.0M$40.0M$24.0M
Notional$2.9B$3.4B$3.7B$3.3B$3.9B$3.6B
Finite-Lived Intangible Assets, Accumulated Amortization$14.8B$15.4B$16.0B$16.6B$17.2B$17.8B
Gross Carrying Amount$31.9B$31.9B$31.9B$31.9B$31.9B$31.9B
Trademarks$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Indefinite- lived intangible impairment$34.8B$34.8B$34.6B$34.6B$34.2B$34.2B
Inventory Net And Inventory Noncurrent$3.6B$3.8B$3.9B$4.4B$4.4B$4.3B
Estimated litigation liability$242.0M$220.0M$0.0$0.0$0.0$0.0
Noncontrolling interests in subsidiaries-$84.0M-$84.0M-$84.0M-$84.0M-$84.0M-$84.0M
Other long-term assets$386.0M$359.0M$369.0M$393.0M$393.0M$308.0M
Preferred Stock, Par or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Preferred Stock, Shares Authorized5M5M5M5M5M5M
Preferred Stock, Shares Outstanding000000
Severance accrual, current$138.0M$92.0M$52.0M$73.0M